No Data
No Data
長江生命科技:二零二三年年報
Changes in Hong Kong stocks | Changjiang Life Technology (00775.HK) rises by nearly 30%. The company will display cancer vaccine research data and cancer vaccine model research cooperation data
Changjiang Life Science (00775.HK) rose by nearly 30%. As of press release, it had risen 21.88% to HK$0.39, with a turnover of HK$13.1371 million.
The Hong Kong stock of Li Ka-shing's Changjiang Life Science and Technology rose nearly 30%. AI helped advance cancer vaccine research. The company will present cancer vaccine research data at the AACR annual meeting.
The Hong Kong stock of Li Ka-shing's Changjiang Life Science and Technology rose nearly 30%. AI helped advance cancer vaccine research. The company will present cancer vaccine research data at the AACR annual meeting.
Changjiang Life Science (00775.HK): New data from preclinical research on KRAS and PD-L1 research cancer vaccines will be exhibited at the AACR 2024 annual meeting
Gelonghui, April 5, 丨 Changjiang Life Technology (00775.HK) announced that the company will present two sets of new pre-clinical research data on rat sarcoma virus oncogene (KRAS) and cell-mediated death-ligand 1 (PD-L1) research cancer vaccines at the 2024 annual meeting of the American Association for Cancer Research (AACR) to be held in San Diego, California, USA. According to the disclosure, KRAS protein is commonly mutated in various cancers and is a key regulator of cell growth and survival, driving tumor growth by promoting uncontrolled cell reproduction and resistance to treatment. PD-L1 protein is
Announcement Highlights: Xiaomi Q4's adjusted net profit increased 236.1% year on year; Xiaopeng Motor Q4's adjusted net loss decreased by 19.9% year on year
Li Ning's revenue in 2023 was 27.598 billion yuan, an increase of 7.0%; China Unicom's profit due to equity holders in 2023 was 18.7 billion yuan, an increase of 11.8% over the previous year.
Changjiang Life Science (00775.HK): Profit attributable to shareholders in 2023 HK$17.25 million
Gelonghui, March 19, 丨 Changjiang Life Technology (00775.HK) announced that for the year ended December 31, 2023, it achieved revenue of HK$5.323 billion, up 1% year on year; recorded profit attributable to shareholders of HK$17.25 million, down 87% year on year, with a basic profit of 0.18 cents per share. The business environment has been turbulent for the past three years. In 2021, as the coronavirus epidemic began to recede, the company promptly raised prices, streamlined operations and improved efficiency to mitigate the impact of inflation, labor shortages and supply chain disruptions. When central banks around the world raised interest rates sharply in 2022 to curb inflation
No Data